Multi-domain Intervention Program for Post-stroke Bone Health in Older Adults (BOUNCE) (BOUNCE)

January 23, 2024 updated by: Hospital Pengajar Universiti Putra Malaysia

Development and Feasibility of a Multi-domain Intervention Program for Post-stroke Bone Health (BOUNCE - Bone Health in Older adUlts' iNtervention Post aCute strokE) in Hospital Pengajar Universiti Putra Malaysia (HPUPM)

The goal of this feasibility randomized controlled trial is to assess the feasibility and compare the changes in bone mineral density before and after the intervention in post-stroke older adults. The main question[s] it aims to answer are:

  • What are the baseline sociodemographic and bone health characteristics of post-stroke older adults in this study?
  • Is it feasible to undertake a larger RCT to assess the effectiveness and implementation of BOUNCE program?
  • Is there a difference in bone loss between groups?
  • Is there a difference in bone turnover markers at baseline and at six months?
  • Is there a difference in the incidence of falls and fragility fractures between groups?
  • How receptive are post-stroke patients/carers to the use of food/exercise diary?
  • What are the perceived motivators and barriers to implementation of BOUNCE program within real clinical settings among healthcare professionals, participants and carers?
  • What is the experience of healthcare professionals, participants and carers undergoing BOUNCE program?

Participants will be divided into two groups:

  1. Standard care
  2. Intervention group (BOUNCE Program) Researchers will compare both groups to see any changes in the bone mineral density and bone turnover markers before and after the intervention.

Study Overview

Status

Recruiting

Detailed Description

Stroke causes secondary osteoporosis, falls and fractures. The 2020 Malaysian Stroke Guideline recommends fall and fracture risk assessment in all older stroke patients, but it does not make a firm recommendation on the interventions to address post-stroke bone loss. Stroke increased the risk of fall by 1.5 times compared to the normal population and quadrupled the risk of fracture. Hip fractures will increase the cost for treatment, hospitalization, operation and complicate the rehabilitation process from the stroke itself.

Hence, our study aims to develop and assess the feasibility of a multi-domain intervention (BOUNCE program) for bone health among older adults with acute stroke. A multi-domain non-pharmacological intervention is proposed due to the complex nature of bone loss in older post-stroke patients such as low serum Vitamin D, sarcopenia, frailty, comorbidity, ageing and hemiparesis. Therefore, this study is designed through the 2021 MRC Framework of Developing and Evaluating Complex Intervention and is divided into 3 phases. The first phase is a systematic review to identify evidence on non-pharmacological interventions for post-stroke bone health. Phase 2 is the development and validation of a novel multi-domain intervention protocol for BOUNCE program through an expert consensus development conference. The final phase will be a feasibility trial of BOUNCE program, which is further divided into two components. The first component is a randomized, controlled, single-blinded feasibility trial (RCT) of 6-months intervention (BOUNCE program) versus standard care, which primarily assesses bone loss through bone mineral density and bone turnover markers. The second component is a qualitative analysis through Focused Group Discussions on the feasibility of BOUNCE program among healthcare professionals, patients and carers. The outcome of this study will inform the next step of evaluation, which is a future full RCT to assess the effectiveness and economic studies before it can be implemented widely.

Study Type

Interventional

Enrollment (Estimated)

70

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Hakimah Mohammad Sallehuddin, MBBS
  • Phone Number: 2568 +60397692893
  • Email: drhakimah@upm.edu.my

Study Locations

    • Selangor
      • Serdang, Selangor, Malaysia, 43400
        • Recruiting
        • Hospital Sultan Abdul Aziz Shah
        • Contact:
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Aged 50 years old and older
  • Neurologist diagnosed acute stroke within 90 days
  • Has baseline biochemical test upon admission to the ward
  • Able to undergo DXA scan
  • Modified Rankin Score of 2 to 3
  • Able to walk with or without aids

Exclusion Criteria:

  • Known underlying malignancy
  • Known major depression or severe psychological illness
  • Known chronic kidney disease stage 3b (eGFR <45ml/min/1.73m2) or more
  • Taken oral glucocorticoids therapy for at least three months
  • Presence of cognitive impairment (ECAQ <7)
  • Presence of coronary artery syndrome or congestive cardiac failure
  • Presence of an uncontrolled respiratory condition
  • Underlying malabsorption syndrome
  • Underlying conditions other than stroke that impairs mobility (eg Severe Osteoarthritis, Parkinson's Disease, Multiple sclerosis)
  • Known osteoporosis or fragility fracture
  • Serum phosphate or calcium abnormalities
  • Discharge to a nursing home or rehabilitation centre
  • Already a participant in another trial/study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Standard Care
Standard post-stroke care
Standard post-stroke care
Experimental: Intervention
BOUNCE Program
Intervention arm: Bone-building exercises will be incorporated into the standard post-stroke exercises, as well as Nutritional intervention consisting of individualized diet plan based on calorie requirement, high-quality protein intake, vitamin D, Calcium and micronutrients with a one-to-one virtual session.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Areal Bone Mineral Density (BMD) at the Neck of Femur as measured by Hologic Dual X-ray Absorptiometry in g/cm2
Time Frame: At baseline and month-6
To examine the difference in Areal BMD change pre and post-intervention between groups
At baseline and month-6

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Recruitment uptake
Time Frame: Throughout study period of average 1 year
Number of participants randomized among screened
Throughout study period of average 1 year
Change in the level Bone Turnover Markers (BTM) as assessed by C-Telopeptide-Cross-Linked Type I Collagen (CTx) in ng/ml and Procollagen Type I N-Terminal Propeptide (PINP) in ng/ml
Time Frame: At baseline and month-6
To examine the difference of BTM change pre and post-intervention between groups
At baseline and month-6
Retention
Time Frame: Assessment at month-4 and month-6
Number of participants followed-up among randomized
Assessment at month-4 and month-6
Treatment adherence
Time Frame: Assessment at month-4 and month-6
Number of participants who adhere to the nutritional and exercise interventions in each group
Assessment at month-4 and month-6
Acceptability
Time Frame: Assessment at month-4 and month-6
Qualitative study using semi-structured interviews (3 Focus group discussions consist of 10 participants, 10 healthcare professionals and 10 carers) on the motivators, barriers and experience of the intervention
Assessment at month-4 and month-6
Side-effects
Time Frame: Assessment at month-4 and month-6
Qualitative study using a semi-structured interview on any side effects of the intervention
Assessment at month-4 and month-6
Falls
Time Frame: Assessment at month-4 and month-6
Number of participants experiencing falls during the study period as assessed by Falls Diary
Assessment at month-4 and month-6
Fracture
Time Frame: Assessment at month-4 and month-6
Number of participants experiencing bone fragility fracture during the study period as assessed by x-ray evidence
Assessment at month-4 and month-6

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Sazlina Shariff-Ghazali, PhD, Universiti Putra Malaysia

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2023

Primary Completion (Estimated)

November 30, 2024

Study Completion (Estimated)

August 31, 2025

Study Registration Dates

First Submitted

March 7, 2023

First Submitted That Met QC Criteria

July 1, 2023

First Posted (Actual)

July 11, 2023

Study Record Updates

Last Update Posted (Actual)

January 25, 2024

Last Update Submitted That Met QC Criteria

January 23, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on Standard Care

3
Subscribe